Showing results (61-70 of 104) with videos related to

Sort By:
Pageof 11
Pediatric Blood & Cancer|September 20, 2008
Myeloablative chemotherapy with autologous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: outcome compared with conventional chemotherapy: a report from the Children's Oncology GroupJonathan L Finlay, Girish Dhall, James M Boyett, et al.
Cureus|May 31, 2016
Re-irradiation of Recurrent Pineal Germ Cell Tumors with Radiosurgery: Report of Two Cases and Review of LiteratureKenneth Wong, Anthony B Opimo, Arthur J Olch, et al.
Pediatric Blood & Cancer|February 23, 2008
Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocolsGirish Dhall, Howard Grodman, Lingyun Ji, et al.
Oncotarget|June 12, 2020
Phase I study of vemurafenib in children with recurrent or progressive BRAF<sup>V600E</sup> mutant brain tumors: Pacific Pediatric Neuro-Oncology Consortium study (PNOC-002)Theodore Nicolaides, Kellie J Nazemi, John Crawford, et al.
Pediatric Blood & Cancer|May 5, 2016
Clinical, Pathological, and Molecular Characterization of Infant Medulloblastomas Treated with Sequential High-Dose ChemotherapyLucie Lafay-Cousin, Amy Smith, Susan N Chi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2010
Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysisStefan Rutkowski, Katja von Hoff, Angela Emser, et al.
Neuro-Oncology|March 30, 2016
Phase I trial of p28 (NSC745104), a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive central nervous system tumors: A Pediatric Brain Tumor Consortium StudyRishi R Lulla, Stewart Goldman, Tohru Yamada, et al.
Pediatric Blood & Cancer|December 2, 2017
Long-term evidence that a pediatric oncology mentorship program for young investigators is feasible and beneficial in the cooperative group setting: A report from the Children's Oncology GroupAdam J Esbenshade, Christopher R Pierson, Amanda L Thompson, et al.
The Lancet. Oncology|June 6, 2020
Response assessment in diffuse intrinsic pontine glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working groupTabitha M Cooney, Kenneth J Cohen, Carolina V Guimaraes, et al.
Pediatric Blood & Cancer|October 13, 2011
Choroid plexus tumors; management, outcome, and association with the Li-Fraumeni syndrome: the Children's Hospital Los Angeles (CHLA) experience, 1991-2010Alexa E Gozali, Barbara Britt, Lisa Shane, et al.
Pageof 11